Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid

Bernhard Olzowy(Ludwig-Maximilians-Universität München), Walter Stummer(University of Münster), Cornelia S. Hundt, K. Bise, Hans J. Reulen, Susanne Stocker(Ludwig-Maximilians-Universität München)
Journal of neurosurgery
October 1, 2002
10.3171/jns.2002.97.4.0970
Cited by 93

Related Papers

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
|The Lancet Oncology|2006|3.4k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k
Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients
|Journal of neurosurgery|2000|880
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
|The Lancet|2019|581
What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?
|Neurosurgery|2015|368